Deutsche Bank
RXII

Deutsche Bank’s GALENA BIOPHARMA INC COM RXII Stock Holding History

Deutsche Bank’s Portfolio RXII Stock Details RXII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-6,792
Closed -$13K – 6608
2014
Q3 		$13K Buy
6,792
+100
+1% +$191 ﹤0.01% 5336
2014
Q2 		$20K Sell
6,692
-2,100
-24% -$6.28K ﹤0.01% 5322
2014
Q1 		$3K Buy
+8,792
New +$3K ﹤0.01% 5323

Deutsche Bank's RXII Position: Q4 2016 in Review

Deutsche Bank sold out of GALENA BIOPHARMA INC COM (RXII) in Q4 2016, closing a stake of 35,472 shares — an estimated $12K sold.

Deutsche Bank first reported a position in RXII in Q2 2013 and held it in 14 quarters. The position peaked at $976K in Q1 2014. 0 funds tracked by Wall St. Rank hold RXII as of Q4 2016.

  • Deutsche Bank reported no remaining GALENA BIOPHARMA INC COM position as of Q4 2016 after selling out during the quarter.
  • Deutsche Bank sold 35,472 GALENA BIOPHARMA INC COM shares in Q4 2016, an estimated $12K.
  • Deutsche Bank first reported a position in GALENA BIOPHARMA INC COM in Q2 2013 and held it in 14 quarters.
  • Deutsche Bank's GALENA BIOPHARMA INC COM position peaked at $976K in Q1 2014.
  • 0 funds tracked by Wall St. Rank held GALENA BIOPHARMA INC COM as of Q4 2016.

Based on Deutsche Bank's 13F filing for Q4 2016, filed 14 Feb 2017.